© 2019 Helomics Corp. All rights reserved.

  • White Twitter Icon
  • Facebook - White Circle
  • White LinkedIn Icon

Press Releases 

July 30, 2019

Three Most Recent Pittsburgh-Based Development Partnerships Demonstrate Value and Recognition for Helomics’ AI-Driven, Patient Derived “Multi-Omic” Discovery Platform

MINNEAPOLIS, Minn., July 30, 2019 (GLOBE NEWSWIRE) – Predictive Oncology (Nasdaq: POAI) (“Predictive On...

July 18, 2019

PITTSBURGH, July 18, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI) subsidiary Helomics, an artificial intelligence (AI) and data-driven functional precision medicine company with the mission of improving the standard of care for cancer patients through in...

Please reload

Archive
Please reload

 Follow Us
  • LinkedIn Social Icon
  • Facebook Basic Square
  • Twitter Basic Square